Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The project will focus on new knowledge on the polymorphism of active ingredients and the advancement of methods for characterizing the solid state of their molecules.
February 22, 2023
By: Anthony Vecchione
Olon Group, a chemical pharmaceutical group, and the Politecnico di Milano, Department of Chemistry, Materials and Chemical Engineering, announced a public-private partnership agreement for a research project on the advanced study of polymorphism and the characterization of the solid state of the molecules of active ingredients. The three-year project involves a PhD program dedicated to the development of new knowledge on the polymorphism of active ingredients and the advancement of methods for characterizing the solid state of their molecules. The program will be overseen by researcher Ajay Suresh, Indian Institute of Science Education and Research. Suresh will work on the project in Italy, in collaboration with Olon and the Department of Chemistry, at the Politecnico di Milano, under the direction of professor Pierangelo Metrangolo, department of chemistry, materials and chemical engineering, and president of the physical and biophysical chemistry division at the International Union of Pure and Applied Chemistry. “The collaboration and exchange of knowledge between two of the leading poles of knowledge and expertise in this area certainly has the potential to produce significant results,” said Metrangolo. “The study of polymorphism is one of the most promising areas of study in terms of engineering of molecules, above all because it lays the foundations for the development of much more sustainable and efficient industrial chemical processes.” Giorgio Bertolini, head of research and development, Olon Group said: “Through this long-term collaboration, we will be able to expand substantially our internal expertise in the analysis and study of the physical state of active ingredients, and at the same time increase our polymorph screening capabilities. Two key areas of expertise to ensure competitiveness on the global pharmaceutical market.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !